- Home
- BANL vs COEP Comparison
BANL vs COEP Comparison
Compare BANL & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BANL
- COEP
- Stock Information
- Founded
- BANL 2015
- COEP 2017
- Country
- BANL Malaysia
- COEP United States
- Employees
- BANL N/A
- COEP N/A
- Industry
- BANL Oil Refining/Marketing
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BANL Energy
- COEP Health Care
- Exchange
- BANL Nasdaq
- COEP Nasdaq
- Market Cap
- BANL 25.3M
- COEP 27.4M
- IPO Year
- BANL 2023
- COEP N/A
- Fundamental
- Price
- BANL $0.75
- COEP $9.60
- Analyst Decision
- BANL
- COEP
- Analyst Count
- BANL 0
- COEP 0
- Target Price
- BANL N/A
- COEP N/A
- AVG Volume (30 Days)
- BANL 693.8K
- COEP 33.0K
- Earning Date
- BANL 04-16-2025
- COEP 08-15-2025
- Dividend Yield
- BANL N/A
- COEP N/A
- EPS Growth
- BANL N/A
- COEP N/A
- EPS
- BANL N/A
- COEP N/A
- Revenue
- BANL $592,517,545.00
- COEP $62,874.00
- Revenue This Year
- BANL N/A
- COEP N/A
- Revenue Next Year
- BANL N/A
- COEP N/A
- P/E Ratio
- BANL N/A
- COEP N/A
- Revenue Growth
- BANL 35.93
- COEP N/A
- 52 Week Low
- BANL $0.55
- COEP $2.31
- 52 Week High
- BANL $1.35
- COEP $13.70
- Technical
- Relative Strength Index (RSI)
- BANL 42.94
- COEP 58.28
- Support Level
- BANL $0.72
- COEP $7.25
- Resistance Level
- BANL $1.03
- COEP $8.86
- Average True Range (ATR)
- BANL 0.09
- COEP 0.63
- MACD
- BANL -0.01
- COEP 0.14
- Stochastic Oscillator
- BANL 15.24
- COEP 99.55
About BANL CBL International Limited
CBL International Ltd is a marine fuel logistics company that provides a one-stop solution for vessel refueling. In the bunkering industry, it is referred to as a bunkering facilitator. It facilitates vessel refueling between ship operators and local physical distributors/traders by purchasing marine fuel, including fossil fuel and alternative fuel, from its suppliers and arranging for the suppliers to deliver the fuel to the customers. The company's customer base comprises container liners, bulk carriers, and tankers. Geographically, the company generates a majority of its revenue from China, followed by Hong Kong, Malaysia, Singapore, South Korea, and other regions.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.